Vesiculab Ltd
13 October 2025
Sector: Scientific Research
Location: Gedling
Vesiculab Ltd is a scientific research company based in Bestwood Village, Gedling Nottinghamshire.
Established in June 2023, the company employs 5 people. Vesiculab provides advanced solutions for research in the field of extracellular vesicles (EVs), nanomedicines, gene therapy and nanoparticle-based vaccines. They support scientists worldwide in facilitating pre and post analytics sample preparation for biotech companies who develop breakthrough therapies and vaccines such as mRNA-LNP vaccine.
Challenges faced
Founder and CEO, Dimitri Aubert, and COO Anne-Laure Aubert were experiencing a number of barriers to growth, with the most significant being access to sufficient capital to scale the business. To grow, Vesiculab needed to build a strong product pipeline, supported by both a dedicated sales and a technical support team.
Since launch the business has grown organically, skills and financial investment in marketing had been limited, making it difficult to compete with more established competitors.
A lack of capital also slowed down product development, limiting speed at which the Company could enhance product design and performance, which was something especially important to overseas customers.
Solution – Support Given
Dimitri and Anne-Laure connected with Chamber Adviser, Prashant Gandabhai who introduced them to the Made Smarter programme. With Prashant’s support Vesiculab secured a Grant of £19,800 which funded new digital systems strengthening quality control processes in line with ISO 9001 standards.
They also accessed support through the Skills Workshops and attended the local Gedling Business Support Network where they benefitted from expert talks, and valuable networking opportunities. More recently, with guidance from Business Advisers, Paul Stuart and Richard Crowden, Vesiculab applied for and secured an £8,000 Export Grant via the Export Accelerator. This funding enabled the company to re-engineer components of its products, making them more suitable for marketing in the US and Asia-Pacific.
The company is now exploring support through the High Growth Accelerator as it prepares for the next phase of scaling and expansion.
Impact – The Difference it’s Made
The funded advice and support has enabled Vesiculab to significantly improve product quality, making their solutions more attractive to existing and prospective customers.
The implementation of the new digital quality control systems has reduced waste in new product design by up to 50%, which has saved huge amounts of energy. The company has also taken steps towards achieving compliance with internationally recognised quality standards expected by biotech and pharmaceuticals companies. Increased overseas sales supported the recruitment of an Export Assistant and plans are underway to further expand to meet growing manufacturing demand.
“The support we received through the Chamber and its funded programmes has been invaluable. The Business Advisers understand the needs of fast-growing businesses such as Vesiculab, and they have genuinely taken interest in our success and we are excited about what the future holds.”
- Dimitri Aubert, Founder and CEO
